Grant Number:	1R01CA124709-01A2 Interpret this number
Primary Investigator:	Maris, John
Organization:	Children'S Hosp Of Philadelphia
Project Title:	The Genetic Basis of Neuroblastoma Tumorigenesis
Fiscal Year:	2008

DESCRIPTION (provided by applicant): Neuroblastoma is a common and lethal pediatric malignancy, but the genetic events that initiate tumorigenesis are largely unknown. We hypothesize that neuroblastoma is a complex disease that results from the interaction of mutant alleles with relatively low to moderate effect on tumor initiation. We now plan to discover neuroblastoma susceptibility genes by performing a definitive whole genome association study in ~5000 neuroblastoma patients from the Children's Oncology Group using a high-density single nucleotide polymorphism (SNP)-based replicative study design. We will compare our cases to two control sets: both pediatric non-cancer patients accessioned from our institution, and adult control subjects matched by region across the country. We propose four Specific Aims: First, we will perform a whole genome scan for association of neuroblastoma with SNPs and SNP haplotypes in 2000 neuroblastoma cases and an equal number of matched controls (both children and adults in parallel analyses). Over 550K SNPs will be surveyed, and we anticipate identifying 25,000-50,000 candidate SNPs for further evaluation. Second, we will identify true disease-associated SNP alleles using a customized genotyping platform enriched for haplotype analyses in an independent set of 2000 cases and again two large control sets. By leveraging the HapMap project and controlling for population substructure, we anticipate that this Aim will identify 10-20 genomic regions as candidates for association with neuroblastoma. Third, we will validate at least 5-10 disease-associated regions in a final independent sample set of 675 cases and two sets of ~675 controls. We will again use a gene-centric haplotyping approach to determine true disease associated variants and candidate genes. Finally, we will definitively identify neuroblastoma predisposition genes through direct resequencing of candidate regions in a carefully selected set of 100 neuroblastoma cases and 100 controls, each equally proportioned between the presence or absence of the SNP/haplotype variant associated with neuroblastoma. Our large panel of tumor reagents and genomics databases will be leveraged to assist in region prioritization and identification of candidate genes for further analysis. The successful completion of this project will provide insight into the underlying genetic etiology of neuroblastoma tumorigenesis. We ultimately plan to translate the discovered neuroblastoma predisposition genes into a prognostic biomarkers and/or a target for new treatment approaches. In addition, the data generated here will rapidly be made available to any academically qualified petitioner interested in associating the SNP genotypes with the robust phenotypic information that we have captured including clinical characteristics, tumor biology, response to therapy and disease outcome. Finally, this project should also help catalyze the field of childhood cancer applied genomics research, and if past lessons from other childhood cancers are repeated, it will identify genes that are fundamentally important in human cancer in general. PUBLIC HEALTH RELEVANCE: Neuroblastoma is a common and lethal childhood cancer for which the genetic basis is poorly understood. Our genome-wide association study is designed to discover the most common variations in the human genome that lead to the development of neuroblastoma. These insights will lead to new molecular diagnostic assays and/or new treatments for this frequently devastating malignancy of young children.




Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid Tumors.
Authors: Modi A. , Lopez G. , Conkrite K.L. , Su C. , Leung T.C. , Ramanan S. , Manduchi E. , Johnson M.E. , Cheung D. , Gadd S. , et al. .
Source: Cancer Research, 2023-10-13 00:00:00.0; 83(20), p. 3462-3477.
PMID: 37584517
Related Citations

Children's Oncology Group's 2023 blueprint for research: Epidemiology.
Authors: Lupo P.J. , Marcotte E.L. , Scheurer M.E. , Poynter J.N. , Spector L.G. , COG Epidemiology Committee .
Source: Pediatric Blood & Cancer, 2023-07-14 00:00:00.0; , p. e30566.
EPub date: 2023-07-14 00:00:00.0.
PMID: 37449937
Related Citations

Genetic Analysis in African American Children Supports Ancestry-Specific Neuroblastoma Susceptibility.
Authors: Testori A. , Vaksman Z. , Diskin S.J. , Hakonarson H. , Capasso M. , Iolascon A. , Maris J.M. , Devoto M. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2022-04-01 00:00:00.0; 31(4), p. 870-875.
PMID: 35131881
Related Citations

GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma.
Authors: Dong Z. , Yeo K.S. , Lopez G. , Zhang C. , Dankert Eggum E.N. , Rokita J.L. , Ung C.Y. , Levee T.M. , Her Z.P. , Howe C.J. , et al. .
Source: Cancer Research, 2021-06-01 00:00:00.0; 81(11), p. 2995-3007.
EPub date: 2021-02-18 00:00:00.0.
PMID: 33602789
Related Citations

A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma.
Authors: Gamble L.D. , Purgato S. , Henderson M.J. , Di Giacomo S. , Russell A.J. , Pigini P. , Murray J. , Valli E. , Milazzo G. , Giorgi F.M. , et al. .
Source: Cancers, 2021-04-09 00:00:00.0; 13(8), .
EPub date: 2021-04-09 00:00:00.0.
PMID: 33918978
Related Citations

Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma.
Authors: Lopez G. , Conkrite K.L. , Doepner M. , Rathi K.S. , Modi A. , Vaksman Z. , Farra L.M. , Hyson E. , Noureddine M. , Wei J.S. , et al. .
Source: Genome Research, 2020 Sep; 30(9), p. 1228-1242.
EPub date: 2020-08-13 00:00:00.0.
PMID: 32796005
Related Citations

LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase.
Authors: Chen D. , Cox J. , Annam J. , Weingart M. , Essien G. , Rathi K.S. , Rokita J.L. , Khurana P. , Cuya S.M. , Bosse K.R. , et al. .
Source: Neoplasia (new York, N.y.), 2020-04-24 00:00:00.0; 22(6), p. 231-241.
EPub date: 2020-04-24 00:00:00.0.
PMID: 32339949
Related Citations

Mitochondrial DNA haplogroups and susceptibility to neuroblastoma.
Authors: Chang X. , Bakay M. , Liu Y. , Glessner J. , Rathi K.S. , Hou C. , Qu H. , Vaksman Z. , Nguyen K. , Sleiman P.M.A. , et al. .
Source: Journal Of The National Cancer Institute, 2020-02-25 00:00:00.0; , .
EPub date: 2020-02-25 00:00:00.0.
PMID: 32096864
Related Citations

ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures.
Authors: Qadeer Z.A. , Valle-Garcia D. , Hasson D. , Sun Z. , Cook A. , Nguyen C. , Soriano A. , Ma A. , Griffiths L.M. , Zeineldin M. , et al. .
Source: Cancer Cell, 2019-11-11 00:00:00.0; 36(5), p. 512-527.e9.
EPub date: 2019-10-17 00:00:00.0.
PMID: 31631027
Related Citations

Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma.
Authors: Egolf L.E. , Vaksman Z. , Lopez G. , Rokita J.L. , Modi A. , Basta P.V. , Hakonarson H. , Olshan A.F. , Diskin S.J. .
Source: American Journal Of Human Genetics, 2019-09-05 00:00:00.0; 105(3), p. 658-668.
EPub date: 2019-08-29 00:00:00.0.
PMID: 31474320
Related Citations

Exploring Shared Susceptibility between Two Neural Crest Cells Originating Conditions: Neuroblastoma and Congenital Heart Disease.
Authors: Testori A. , Lasorsa V.A. , Cimmino F. , Cantalupo S. , Cardinale A. , Avitabile M. , Limongelli G. , Russo M.G. , Diskin S. , Maris J. , et al. .
Source: Genes, 2019-08-30 00:00:00.0; 10(9), .
EPub date: 2019-08-30 00:00:00.0.
PMID: 31480262
Related Citations

Neuroblastoma in relation to joint effects of vitamin A and maternal and offspring variants in vitamin A-related genes: A report of the Children's Oncology Group.
Authors: Mazul A.L. , Weinberg C.R. , Engel S.M. , Siega-Riz A.M. , Zou F. , Carrier K.S. , Basta P.V. , Vaksman Z. , Maris J.M. , Diskin S.J. , et al. .
Source: Cancer Epidemiology, 2019 Aug; 61, p. 165-171.
EPub date: 2019-07-04 00:00:00.0.
PMID: 31279991
Related Citations

Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor.
Authors: Cimmino F. , Avitabile M. , Diskin S.J. , Vaksman Z. , Pignataro P. , Formicola D. , Cardinale A. , Testori A. , Koster J. , de Torres C. , et al. .
Source: International Journal Of Cancer, 2018-08-21 00:00:00.0; , .
EPub date: 2018-08-21 00:00:00.0.
PMID: 30132831
Related Citations

Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.
Authors: Harenza J.L. , Diamond M.A. , Adams R.N. , Song M.M. , Davidson H.L. , Hart L.S. , Dent M.H. , Fortina P. , Reynolds C.P. , Maris J.M. .
Source: Scientific Data, 2017-12-05 00:00:00.0; 4, p. 170183.
EPub date: 2017-12-05 00:00:00.0.
PMID: 29206221
Related Citations

Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma risk.
Authors: Chang X. , Zhao Y. , Hou C. , Glessner J. , McDaniel L. , Diamond M.A. , Thomas K. , Li J. , Wei Z. , Liu Y. , et al. .
Source: Nature Communications, 2017-09-18 00:00:00.0; 8(1), p. 569.
EPub date: 2017-09-18 00:00:00.0.
PMID: 28924153
Related Citations

LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis.
Authors: Zhu S. , Zhang X. , Weichert-Leahey N. , Dong Z. , Zhang C. , Lopez G. , Tao T. , He S. , Wood A.C. , Oldridge D. , et al. .
Source: Cancer Cell, 2017-09-11 00:00:00.0; 32(3), p. 310-323.e5.
EPub date: 2017-08-31 00:00:00.0.
PMID: 28867147
Related Citations

Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.
Authors: Harenza J.L. , Diamond M.A. , Adams R.N. , Song M.M. , Davidson H.L. , Hart L.S. , Dent M.H. , Fortina P. , Reynolds C.P. , Maris J.M. .
Source: Scientific Data, 2017-03-28 00:00:00.0; 4, p. 170033.
EPub date: 2017-03-28 00:00:00.0.
PMID: 28350380
Related Citations

Genetic susceptibility to neuroblastoma.
Authors: Tolbert V.P. , Coggins G.E. , Maris J.M. .
Source: Current Opinion In Genetics & Development, 2017 Feb; 42, p. 81-90.
EPub date: 2017-04-28 00:00:00.0.
PMID: 28458126
Related Citations

Neuroblastoma Survivors Are At Increased Risk For Second Malignancies: A Report From The International Neuroblastoma Risk Group Project
Authors: Applebaum M.A. , Vaksman Z. , Lee S.M. , Hungate E.A. , Henderson T.O. , London W.B. , Pinto N. , Volchenboum S.L. , Park J.R. , Naranjo A. , et al. .
Source: European Journal Of Cancer (oxford, England : 1990), 2016-12-26 00:00:00.0; 72, p. 177-185.
PMID: 28033528
Related Citations

A family-based study of gene variants and maternal folate and choline in neuroblastoma: a report from the Children's Oncology Group.
Authors: Mazul A.L. , Siega-Riz A.M. , Weinberg C.R. , Engel S.M. , Zou F. , Carrier K.S. , Basta P.V. , Vaksman Z. , Maris J.M. , Diskin S.J. , et al. .
Source: Cancer Causes & Control : Ccc, 2016 Oct; 27(10), p. 1209-18.
PMID: 27541142
Related Citations

Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers.
Authors: Walsh K.M. , Whitehead T.P. , de Smith A.J. , Smirnov I.V. , Park M. , Endicott A.A. , Francis S.S. , Codd V. , ENGAGE Consortium Telomere Group , Samani N.J. , et al. .
Source: Carcinogenesis, 2016 06; 37(6), p. 576-82.
PMID: 27207662
Related Citations

Advances In The Translational Genomics Of Neuroblastoma: From Improving Risk Stratification And Revealing Novel Biology To Identifying Actionable Genomic Alterations
Authors: Bosse K.R. , Maris J.M. .
Source: Cancer, 2016-01-01 00:00:00.0; 122(1), p. 20-33.
PMID: 26539795
Related Citations

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
Authors: Oldridge D.A. , Wood A.C. , Weichert-Leahey N. , Crimmins I. , Sussman R. , Winter C. , McDaniel L.D. , Diamond M. , Hart L.S. , Zhu S. , et al. .
Source: Nature, 2015-12-17 00:00:00.0; 528(7582), p. 418-21.
EPub date: 2015-11-11 00:00:00.0.
PMID: 26560027
Related Citations

A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis.
Authors: Schnepp R.W. , Khurana P. , Attiyeh E.F. , Raman P. , Chodosh S.E. , Oldridge D.A. , Gagliardi M.E. , Conkrite K.L. , Asgharzadeh S. , Seeger R.C. , et al. .
Source: Cancer Cell, 2015-11-09 00:00:00.0; 28(5), p. 599-609.
EPub date: 2015-10-17 00:00:00.0.
PMID: 26481147
Related Citations

CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.
Authors: Russell M.R. , Penikis A. , Oldridge D.A. , Alvarez-Dominguez J.R. , McDaniel L. , Diamond M. , Padovan O. , Raman P. , Li Y. , Wei J.S. , et al. .
Source: Cancer Research, 2015-08-01 00:00:00.0; 75(15), p. 3155-66.
EPub date: 2015-06-22 00:00:00.0.
PMID: 26100672
Related Citations

Common genetic variants in NEFL influence gene expression and neuroblastoma risk.
Authors: Capasso M. , Diskin S. , Cimmino F. , Acierno G. , Totaro F. , Petrosino G. , Pezone L. , Diamond M. , McDaniel L. , Hakonarson H. , et al. .
Source: Cancer Research, 2014-12-01 00:00:00.0; 74(23), p. 6913-24.
EPub date: 2014-10-13 00:00:00.0.
PMID: 25312269
Related Citations

Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
Authors: Pinto N. , Gamazon E.R. , Antao N. , Myers J. , Stark A.L. , Konkashbaev A. , Im H.K. , Diskin S.J. , London W.B. , Ludeman S.M. , et al. .
Source: Clinical Pharmacology And Therapeutics, 2014 Jun; 95(6), p. 644-52.
EPub date: 2014-02-18 00:00:00.0.
PMID: 24549002
Related Citations

Rare variants in TP53 and susceptibility to neuroblastoma.
Authors: Diskin S.J. , Capasso M. , Diamond M. , Oldridge D.A. , Conkrite K. , Bosse K.R. , Russell M.R. , Iolascon A. , Hakonarson H. , Devoto M. , et al. .
Source: Journal Of The National Cancer Institute, 2014 Apr; 106(4), p. dju047.
EPub date: 2014-03-14 00:00:00.0.
PMID: 24634504
Related Citations

Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.
Authors: Capasso M. , Diskin S.J. , Totaro F. , Longo L. , De Mariano M. , Russo R. , Cimmino F. , Hakonarson H. , Tonini G.P. , Devoto M. , et al. .
Source: Carcinogenesis, 2013 Mar; 34(3), p. 605-11.
EPub date: 2012-12-07 00:00:00.0.
PMID: 23222812
Related Citations

The genetic landscape of high-risk neuroblastoma.
Authors: Pugh T.J. , Morozova O. , Attiyeh E.F. , Asgharzadeh S. , Wei J.S. , Auclair D. , Carter S.L. , Cibulskis K. , Hanna M. , Kiezun A. , et al. .
Source: Nature Genetics, 2013 Mar; 45(3), p. 279-84.
EPub date: 2013-01-20 00:00:00.0.
PMID: 23334666
Related Citations

Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival.
Authors: Gamazon E.R. , Pinto N. , Konkashbaev A. , Im H.K. , Diskin S.J. , London W.B. , Maris J.M. , Dolan M.E. , Cox N.J. , Cohn S.L. .
Source: Journal Of The National Cancer Institute, 2013-02-20 00:00:00.0; 105(4), p. 302-9.
EPub date: 2012-12-14 00:00:00.0.
PMID: 23243203
Related Citations

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.
Authors: Diskin S.J. , Capasso M. , Schnepp R.W. , Cole K.A. , Attiyeh E.F. , Hou C. , Diamond M. , Carpenter E.L. , Winter C. , Lee H. , et al. .
Source: Nature Genetics, 2012 Oct; 44(10), p. 1126-30.
EPub date: 2012-09-02 00:00:00.0.
PMID: 22941191
Related Citations

Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.
Authors: Bosse K.R. , Diskin S.J. , Cole K.A. , Wood A.C. , Schnepp R.W. , Norris G. , Nguyen B. , Jagannathan J. , Laquaglia M. , Winter C. , et al. .
Source: Cancer Research, 2012-04-15 00:00:00.0; 72(8), p. 2068-78.
EPub date: 2012-02-20 00:00:00.0.
PMID: 22350409
Related Citations

Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans.
Authors: Latorre V. , Diskin S.J. , Diamond M.A. , Zhang H. , Hakonarson H. , Maris J.M. , Devoto M. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2012 Apr; 21(4), p. 658-63.
EPub date: 2012-02-10 00:00:00.0.
PMID: 22328350
Related Citations

Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.
Authors: Nguyen B. , Diskin S.J. , Capasso M. , Wang K. , Diamond M.A. , Glessner J. , Kim C. , Attiyeh E.F. , Mosse Y.P. , Cole K. , et al. .
Source: Plos Genetics, 2011 Mar; 7(3), p. e1002026.
EPub date: 2011-03-17 00:00:00.0.
PMID: 21436895
Related Citations

Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Authors: Wang K. , Diskin S.J. , Zhang H. , Attiyeh E.F. , Winter C. , Hou C. , Schnepp R.W. , Diamond M. , Bosse K. , Mayes P.A. , et al. .
Source: Nature, 2011-01-13 00:00:00.0; 469(7329), p. 216-20.
EPub date: 2010-12-01 00:00:00.0.
PMID: 21124317
Related Citations

Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma.
Authors: Devoto M. , Specchia C. , Laudenslager M. , Longo L. , Hakonarson H. , Maris J. , Mossé Y. .
Source: Human Heredity, 2011; 71(2), p. 135-9.
EPub date: 2011-07-06 00:00:00.0.
PMID: 21734404
Related Citations

Optimal False Discovery Rate Control for Dependent Data.
Authors: Xie J. , Cai T.T. , Maris J. , Li H. .
Source: Statistics And Its Interface, 2011; 4(4), p. 417-430.
PMID: 23378870
Related Citations

Recent advances in neuroblastoma.
Authors: Maris J.M. .
Source: The New England Journal Of Medicine, 2010-06-10 00:00:00.0; 362(23), p. 2202-11.
PMID: 20558371
Related Citations

A hidden Markov random field model for genome-wide association studies.
Authors: Li H. , Wei Z. , Maris J. .
Source: Biostatistics (oxford, England), 2010 Jan; 11(1), p. 139-50.
EPub date: 2009-10-12 00:00:00.0.
PMID: 19822692
Related Citations

Inhibition of ALK signaling for cancer therapy.
Authors: Mossé Y.P. , Wood A. , Maris J.M. .
Source: Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research, 2009-09-15 00:00:00.0; 15(18), p. 5609-14.
EPub date: 2009-09-08 00:00:00.0.
PMID: 19737948
Related Citations

Copy number variation at 1q21.1 associated with neuroblastoma.
Authors: Diskin S.J. , Hou C. , Glessner J.T. , Attiyeh E.F. , Laudenslager M. , Bosse K. , Cole K. , Mossé Y.P. , Wood A. , Lynch J.E. , et al. .
Source: Nature, 2009-06-18 00:00:00.0; 459(7249), p. 987-91.
PMID: 19536264
Related Citations

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
Authors: Capasso M. , Devoto M. , Hou C. , Asgharzadeh S. , Glessner J.T. , Attiyeh E.F. , Mosse Y.P. , Kim C. , Diskin S.J. , Cole K.A. , et al. .
Source: Nature Genetics, 2009 Jun; 41(6), p. 718-23.
EPub date: 2009-05-03 00:00:00.0.
PMID: 19412175
Related Citations

Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidy.
Authors: Attiyeh E.F. , Diskin S.J. , Attiyeh M.A. , Mossé Y.P. , Hou C. , Jackson E.M. , Kim C. , Glessner J. , Hakonarson H. , Biegel J.A. , et al. .
Source: Genome Research, 2009 Feb; 19(2), p. 276-83.
EPub date: 2009-01-13 00:00:00.0.
PMID: 19141597
Related Citations

Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms.
Authors: Diskin S.J. , Li M. , Hou C. , Yang S. , Glessner J. , Hakonarson H. , Bucan M. , Maris J.M. , Wang K. .
Source: Nucleic Acids Research, 2008 Nov; 36(19), p. e126.
EPub date: 2008-09-10 00:00:00.0.
PMID: 18784189
Related Citations

Identification of ALK as a major familial neuroblastoma predisposition gene.
Authors: Mossé Y.P. , Laudenslager M. , Longo L. , Cole K.A. , Wood A. , Attiyeh E.F. , Laquaglia M.J. , Sennett R. , Lynch J.E. , Perri P. , et al. .
Source: Nature, 2008-10-16 00:00:00.0; 455(7215), p. 930-5.
EPub date: 2008-08-24 00:00:00.0.
PMID: 18724359
Related Citations

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.
Authors: Maris J.M. , Mosse Y.P. , Bradfield J.P. , Hou C. , Monni S. , Scott R.H. , Asgharzadeh S. , Attiyeh E.F. , Diskin S.J. , Laudenslager M. , et al. .
Source: The New England Journal Of Medicine, 2008-06-12 00:00:00.0; 358(24), p. 2585-93.
EPub date: 2008-05-07 00:00:00.0.
PMID: 18463370
Related Citations